Phaarmasia's Q2 financials show decline in sales and profitability, receives 'Strong Sell' call from MarketsMOJO
Phaarmasia, a microcap pharmaceutical company, has reported a decline in its financial performance for the quarter ending September 2024. While there has been an improvement in profitability, there are concerning factors such as a decrease in net sales and operating profit. Investors should carefully evaluate these results before making any investment decisions.
Phaarmasia, a microcap pharmaceutical company, has recently declared its financial results for the quarter ending September 2024. The company has received a 'Strong Sell' call from MarketsMOJO, indicating a negative outlook for its stock.
According to the financial report, Phaarmasia has seen a decline in its financial performance in the second quarter of the fiscal year 2024-25. The company's score has fallen from 5 to -6 in the last three months.
However, there are some positive aspects in the financials for Phaarmasia. The company's Profit After Tax (PAT) for the nine-month period is higher at Rs 0.11 crore compared to the previous 12-month period of Rs -1.08 crore. This indicates an improvement in profitability for the company.
On the other hand, there are also some concerning factors in the financials. The company's Net Sales for the quarter have fallen by -25.9% compared to the average of the previous four quarters. This shows a negative trend in sales for the company in the near term.
Additionally, Phaarmasia's Operating Profit (PBDIT) for the quarter is at its lowest in the last five quarters, indicating a negative trend in the company's profitability. The Operating Profit Margin has also decreased, showing a decline in the company's efficiency.
Furthermore, the company's Profit Before Tax less Other Income (PBT) for the quarter is at its lowest in the last five quarters, indicating a negative trend in its profitability. The Earnings per Share (EPS) for the quarter have also decreased, showing a decline in the company's earnings for its shareholders.
Overall, Phaarmasia's financial results for the quarter ending September 2024 have shown a negative trend in its performance. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
